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ABSTRACT 
The current goal of treatments in irritable bowel syndrome focus primarily on symptom 
management and attempts to improve quality of life. Several treatments are at the 
disposal of physicians, with lifestyle and dietary management, pharmacological 
treatments, and psychological interventions as the most used and recommended. 
Psychological treatments have been proposed as viable alternatives or compliments to 
existing models of care. Most forms of psychological therapies studied have been 
shown to be helpful in reducing symptoms and in improving psychological components 
of anxiety/depression, and health-related quality of life. According to current 
NICE/NHS guidelines, physicians should consider referral for psychological treatment 
in patients who do not respond to pharmacotherapy for a period of 12 months and 
develop a continuing symptom profile (described as refractory irritable bowel 
syndrome). So far, Cognitive Behavioural Therapy has been the most well-studied and 
has been presented as the most promising treatment. However, some studies have 
challenged the effectiveness of Cognitive Behavioural Therapy for irritable bowel 
syndrome, with one study highlighting Cognitive Behavioural Therapy as not being 
more effective than an attention control placebo and another showing effects to wane at 
6 months follow-up. A review of mind/body approaches to irritable bowel syndrome has 
therefore suggested that approaches that target mechanisms other than thought content 
change might be helpful, specifically mindfulness and acceptance based approaches. In 
this article, we intend to review these new psychological treatment approaches in an 
attempt to raise awareness of these alternative treatments to gastroenterologists that 
work with this clinical syndrome.  
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1. INTRODUCTION 
A recent systematic review and meta-analysis has demonstrated a global prevalence 
of IBS of 11%, a percentage that varies considerably in some instances, according to 
geographic region and diagnostic criteria used to define IBS (1). On the other hand, the 
percentage of patients seeking health care related to IBS reaches 12% in primary care 
practices and is by far the largest subgroup seen in gastroenterology clinics (2).   
IBS has been defined according to the new Rome IV criteria (3) as recurrent 
abdominal pain associated with two or more of the following: related to defecation; 
associated with change in frequency of stool; associated with change in consistency of 
stool. Symptom onset should occur at least 6 months before the diagnosis, and 
symptoms should be present on average at least 1 day a week in the last 3 months.  
The etiology and pathophysiology of IBS is unknown; several pathogenic factors 
responsible for the IBS have been proposed, such as genetic and environmental factors 
(4), abnormal gut motility (5), visceral hypersensitivity (6), post-infectious inflammatory 
mechanisms (7), psychological morbidity, physical, emotional and sexual abuse (8), 
bacterial overgrowth (9) and changes in intestinal microbiota (10), among others. 
However, none of them seems to clearly explain the mechanisms that trigger the 
syndrome. 
Nowadays, a model taking into account the numerous physiological symptoms (e.g. 
altered motility, gut hypersensitivity) but also psychosocial factors and interactions 
between brain and gut seems to be shifting the understanding of IBS (11). 
This biopsychosocial interpretation of IBS (11), heavily influenced by discoveries in 
the fields of psychosomatics and psychoneuroimmunology (12,13), is now recognized as 
one of the most complete and best fitting models for this illness   
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In the model we can see how changes in early life/premorbid genetic and 
environmental (parenting, infection) factors might play a role in the development of both 
psychosocial (susceptibility to stress, psychological illness, psychological traits) and 
physiological (abnormal motility, visceral hypersensitivity) factors leading to the 
expression of IBS symptoms and coping behaviours. Also, interplay between 
psychosocial and physiological factors via the interactions between CNS and the ENS are 
highlighted as an influence in IBS expression (11).  These biopsychosocial interactions 
are therefore thought to have an impact on patients’ quality of life and the use they make 
of health care. 
Historically, the absence of a structural or organic explanation for IBS and anecdotal 
observations of patients’ behaviour has always been seen as support to the possible 
presence of psychological morbidity.  
Early research described the aetiology of IBS to be linked with hypochondriasis or 
psychogenic traits (14) with some authors going as far as considering IBS to be part of a 
diagnosable psychiatric illness (15). This is not surprising as most studies show that 
between 54% and 94% of IBS patients meet criteria for at least 1 (Axis I) psychiatric 
disorder (16). IBS patients usually have different associated mental disorders with the 
most frequent being anxiety (69%) followed by affective disorders (38%) (17). Within 
the first, nervousness, rumination, panic attacks, posttraumatic stress, social phobia, 
somatization and eating disorder are included. Among the latter, sleep disorders, loss of 
appetite and exhaustion (18-20). 
This is particularly relevant given the current guidelines for interventions in IBS. The 
current goal of treatments in IBS focus primarily on symptom management and attempts 
to improve quality of life (21). Therefore, after a positive diagnosis has been made, 
several treatments are at the disposal of physicians with lifestyle and dietary management, 
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pharmacological treatments, and psychological interventions as the most used and 
recommended (21, 22). Worthy of note is the practice guideline for the management of 
IBS-constipation (23), recently published in this journal.  
Figure 1 presents an adapted flow chart of care resulting from a consensus between 
the recommendations of the British Society of Gastroenterology (22), the National 
Institute for Health and Clinical Excellence (NICE) (24) and the American College of 
Gastroenterology (25).  
Although lifestyle and dietary management (e.g. exercise, fibre intake) have limited 
efficacy in IBS, in general, their safety and general health net benefits seem to justify 
their inclusion as a first line of management (22). Regarding conventional medical 
treatment (i.e. pharmacological), several studies and reviews have highlighted the limited 
efficacy of these approaches in providing adequate relief for IBS patients. Nevertheless, 
some drugs that are being used lately, such as linaclotide, rifaximine, melatonine or 
antidepressants, are producing good results (26). Therefore, aapproaches such as 
psychological treatments have been proposed as viable alternatives or compliments to 
existing models of care (27).   
Most forms of psychological therapies studied have been shown to be helpful in 
reducing symptoms and in improving psychological components of anxiety/depression, 
and health-related quality of life (22, 27, 28). The success of psychological therapies for 
IBS global outcomes has seen it being implemented as a standard adjunctive treatment in 
the UK. According to current NICE/NHS (24) guidelines, physicians should consider 
referral for psychological treatment in patients who do not respond to pharmacotherapy 
for a period of 12 months and develop a continuing symptom profile (described as 
refractory IBS). So, those patients who do not get better with first line treatments can 
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benefit from psychological interventions, which may reduce pain and other symptoms 
and improve quality of life. 
The most studied and used forms of psychological treatment for IBS have been 
relaxation training, brief psychodynamic psychotherapy, CBT, hypnotherapy and several 
forms of self-help. These forms of treatment have been used both in individual and group 
settings and are thought to be acceptable to patients, especially those who identify 
psychological factors as triggers for their IBS (29).  Table 1 provides a simple overview 
of the most important psychological therapies in terms of understanding of 
(psycho)pathology, objectives in therapy, techniques used, and strengths/weaknesses, in 
an attempt to facilitate their comprehension beyond the psychological field.                     
So far, CBT has been the most well-studied and has been presented as the most 
promising treatment (26, 30).  However, some studies have challenged the effectiveness 
of CBT for IBS with one study highlighting CBT as not being more effective than an 
attention control placebo (31) and another showing effects to wane at 6 months follow-
up (32). Also, studies looking at active components of CBT, found that cognitive change 
(one of the key components of CBT) was not associated with any significant changes in 
outcomes (33). A review of mind/body approaches to IBS has therefore suggested that 
approaches that target mechanisms other than thought content change might be helpful, 
specifically mindfulness and acceptance based approaches (29). 
In this article, we intend to review these new psychological treatment approaches in 
an attempt to raise awareness of these alternative treatments to gastroenterologists that 
work with this clinical syndrome.  
Bibliographic search strategy 
The biomedical literature search was performed in the PubMed database of the US 
National Library of Medicine (pubmed.gov). The MeSH (Medical Subjects Headings) 
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terms used to conduct the review and search of scientific evidence were: Irritable Bowel 
Syndrome [in the title] combined with Mindfulness [in the title] and with Acceptance and 
Commitment Therapy or Acceptance-Commitment, respectively, using the Boolean 
operator AND / OR. The results obtained were filtered with the following limits: Types 
of studies: Systematic Reviews, Meta-Analysis, Guideline, Practice Guideline, 
Consensus Development Conference (and Consensus Development Conference NIH), 
Randomized Controlled Trial, Controlled Clinical Trial and Clinical Trial; Age: adults 
(19 or more years); Language: English and / or Spanish; and with, at least, an Abstract.    
Database was searched for relevant studies published up until July 2016. 
  
Initially, the title, abstract, and keywords of every record identified with the search 
strategy were screened. All potentially relevant articles were retained, and the full text 
of these studies obtained and evaluated in detail.  Irrelevant articles were excluded by 
title or abstract. Foreign language papers were translated where necessary. 
One author (BS) carried out data extraction which was then assessed by another author 
(NBF). Differences between reviewers were resolved by discussion until a consensus was 
reached. 
2. THE PSYCHOLOGY OF IBS 
2.1.The psychosocial profile of the IBS patient 
Although physical symptoms are at the forefront of the IBS patient presentation, 
several studies have shown that a key factor in the maintenance and aggravation of IBS 
relates to psychosocial factors (cognitive and emotional) (34). Most patients are likely to 
report experiences such as worry about their symptoms, consequences and duration, 
anxiety, depression, stress, shame and anger (35,36). Within these psychosocial 
phenomena, one that seems to be more commonly reported is GSA, that has been defined 
as “the cognitive, affective and behavioural response stemming from fear of 
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gastrointestinal sensations, symptoms, and the context in which these visceral sensations 
and symptoms occur” (37). GSA is thought to contribute to IBS maintenance, by acting 
as an endogenous stressor that perpetuates alterations in autonomic and neuroendocrine 
responses even in the absence of an external stressor (38). The literature has shown that 
higher levels of GSA are related to higher symptom severity and lower quality of life in 
IBS (37, 39, 40).  
Linked to GSA is the behaviour displayed by IBS patients, with avoidance being used 
as the main strategy to cope with the illness aversive experiences, even in the absence of 
symptoms (41). The patients tend to avoid situations or events such as certain foods or 
food related situations (e.g. eating out); social or work related situations (e.g. gatherings 
or meetings); leisure or travelling; personal relationships and intimate contact (42). Even 
though most patients believe this type of response as being essential for the management 
of their condition, they also recognise this to be the main cause behind their suffering 
(43).  
The literature seems to support this with several studies showing that avoidant coping 
is associated with poorer quality of life, high levels of anxiety and depression (44, 45). 
Further to this, it has also been shown that recurrent avoidance as a coping strategy is 
only effective in the short term, having a rebound effect in the long term (for example, 
the more one tries to eliminate a thought, the more frequent it is) (46-48).  
Strategies such as distraction are also not useful and in a similar way can increase 
pain awareness (49).  Therefore, it is suggested that it’s not the content or nature of the 
distressing experiences (physical or psychological) that is at the heart of suffering in IBS, 
but rather, how patients relate to these experiences and try to deal with them. 
The alternative seems to be discriminating, observing and accepting private 
experiences without trying to alter in form but in function of the behaviour (50,51). From 
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this perspective, the goal of psychological intervention is then to help the patient develop 
and enhance skills that allow him/her to view and accept the private events related to 
his/her illness (thoughts and feelings of shame or guilt, fear, anxiety, stress, specific 
symptoms, etc.), without changing them, directing and maintaining behaviour toward 
his/her values and life goals.  
2.2. Contextual Behavioural Models and IBS 
As previously noted, some authors (29) have recommended that psychological 
treatments of IBS should not focus on changing the form and frequency of the symptoms 
or experiences related to IBS, but to change how patients deal with these experiences 
instead.  
Treatment models developed from a Contextual Behavioural (or Third Wave) 
perspective seem to address this issue. These new psychological treatments have arisen 
as a result of significant shifts in philosophy of science (from mechanism to functional 
contextualism) (52) and the advance in the study of language and cognition as forms of 
behaviour (Relational Frame Theory, 53).  
As a whole, these treatment models aim to: (a) build broad, flexible and effective 
behavioural repertoires in the patient, that are in line with their personal values; (b) by 
modifying the way the patient relates to their experiences (symptoms, thoughts, emotions 
and sensations) so that instead of focusing on eliminating them (53, 54), the patient can 
effect valued behaviour in their presence; and (c) instil moment-by-moment awareness 
so that the patient can notice the context and function of their experiences whilst not 
becoming entangled in them to the point they dictate their behaviour.   
Third-wave approaches include a wide number of therapeutic models such as DBT 
(55); MBCT (56); BA (57) as well as FAP (58).  
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For the purposes of this article, we will be using ACT as a frame of reference, as it 
provides the most comprehensive account of how these interventions can be useful for 
IBS whilst also having the most robust evidence base (59).  
ACT brings a new conceptualization of the suffering of patients with IBS in the 
following way: “A proportion of IBS patients can be functionally characterized by the 
use of behaviours that seek to control, eliminate or alter the physical, emotional and 
cognitive experiences associated with IBS both in the presence or absence of symptoms. 
These behaviours seem to be motivated by an excessive fusion with a self 
conceptualization of being an IBS patient; fusion with unhelpful illness specific beliefs or 
cognitions; and by a dominance of feared future consequences or comparison with an 
idealized past. IBS patients also tend to choose to engage in these avoidant behaviours 
that provide short-term relief from their experiences over engaging in behaviours that 
are values-consistent and that might lead to better life satisfaction on the long-term.” 
(60). 
These are simultaneously occurring processes that contribute to this process, known 
as psychological inflexibility (PI), narrowing the patient’s repertoire and taking him to 
inaction, persistent avoidance and to an increasing limitation of life (61). 
Acceptance and Commitment Therapy (pronounced as one word, “ACT”; 62) is a 
new behavioural therapeutic approach that uses processes of acceptance, defusion (see 
below), commitment and behaviour change to increase psychological flexibility, defined 
as “the ability to contact the present moment more fully as a conscious human being, and 
to either change or persist in behaviours when doing so serves valued ends” (63).  
The use of defusion in ACT could be behaviourally described as a way to train 
discrimination between private events and the individual self, i.e. the individual is able to 
observe events such as thoughts, emotions, memories or physical sensations as part of a 
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repertoire of experiences that a human being is likely to experience, without becoming 
entangled in these experiences to a point that it exerts unduly influence on their behaviour 
(64).  In order to contact this type of discrimination on a moment-by-moment basis, ACT 
also attempts to reinforce a sense of being here and now in patients through mindfulness 
practices. In this defused stance, the patient is then more likely to be willing (or accepting) 
to hold distressing experiences, if it then allows him/her to move and behave coherently 
towards a valued end (e.g. family, friendships). 
Some mindfulness practices are described and used in more depth in other third-wave 
therapies like MBSR program (65), one of the first procedures to integrate Eastern 
practices such as meditation and yoga to manage chronic pain and illness. Similarly, 
MBCT includes formal meditation and promotes a decentred view of thoughts, emotions 
and bodily sensations (66).  
It should be noted, however, that is important to look at the function of MBSR and 
MBCT procedures. Although these techniques are aimed to train the person to become 
aware of the symptoms and not behave accordingly to them (that is, to change the function 
of the symptoms), they can be easily interpreted or used as a way to reduce or change the 
symptoms (and, in that case, behaving accordingly to them). 
This model has received a lot of support and has proved to be very effective in health 
conditions (59) like diabetes (67), epilepsy (68), tinnitus (69) and chronic pain (70-72), 
being considered the possibility of its application to IBS (73,74). 
3. EVIDENCE OF THE APPLICATION OF THIRD GENERATION 
THERAPIES TO IBS 
Some encouraging results have been found in the application of third-wave 
psychological therapies with IBS.   
12 
 
The following is a narrative review of studies on the application of mindfulness 
techniques with CBT components, the application of mindfulness techniques alone and, 
finally, the application of ACT. 
3.1 Mindfulness combined with CBT 
One study (75) applied a CBT based protocol combining mindfulness techniques 
and exposure, aiming at reducing GSA. Inclusion criteria were female gender and age 
18–65 years; patients were excluded if any somatic or psychiatric disorder deemed to 
interfere with treatment was present.  Mindfulness component allows patients to be less 
likely to act on impulses, which, together with the exposure component (provocation of 
symptoms, prevention of response and exposure to situations that evoke symptoms) 
helps the patient accept his/her symptoms and aversive thoughts. This protocol lead to a 
significant improvement in all symptoms (except for diarrhoea), and quality of life. The 
same effects were observed in an internet based version of the same protocol, and were 
maintained up to 6 months (76,77). 
3.2 Mindfulness alone 
The first non-controlled trial (78) was conducted in a Veteran population, with the 
following exclusion criteria: (i) psychotic disorder; (ii) mania or bipolar disorder; (iii) 
personality disorders; (iv) suicidal or homicidal ideation; (v) active substance abuse or 
dependence. Results showed that participation in MBSR group was associated with 
improvements in IBS-related quality of life and GSA. Changes in mindfulness skills 
were correlated with improvements in GSA among those meeting Rome IBS criteria, 
and there was a significant decrease in the percentage of subjects meeting Rome IBS 
criteria over 6-months follow-up.  
A randomized controlled clinical trial of the application of mindfulness to IBS (79), 
was conducted in a female only population who have a medical diagnosis of IBS and 
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who also meet the Rome II criteria for IBS. Exclusion criteria included: 1) diagnosis of 
mental illness with psychotic features; 2) a history of an inpatient admission for 
psychiatric disorder within the past two years; 3) a history or current symptoms of 
inflammatory bowel disease or gastrointestinal malignancy; 4) active liver or pancreatic 
disease; 5) uncontrolled lactose intolerance; 6) celiac disease; 7) a history of abdominal 
trauma or surgery involving gastrointestinal resection; or 8) pregnancy or intention to 
become pregnant during the study. This protocol involved an 8-week mindfulness 
training that included techniques such as body scan, meditation, yoga and exercises that 
help the patient learn to observe thoughts and body sensations non-judgementally. This 
protocol had a clinically significant therapeutic effect on the severity of bowel 
symptoms (26.4% reduction compared to 6.2% in the control group) and improved the 
quality of life related to health, even at three months follow-up. In addition, the protocol 
had also an effect on psychological symptoms (anxiety, general severity, visceral 
anxiety), that was thought to have been mediated by an increase in mindfulness (79). 
The authors suggest that the program allows the patient to learn specific techniques with 
lasting effects, which can be performed in groups, being more cost-effective than other 
treatments such as CBT or hypnosis. 
A second controlled study (80) was conducted with the following exclusion criteria: 
(i) diagnosis of a DSM-IV axis I mood, anxiety, or psychotic disorder; (ii) current use of 
antipsychotics; or (iii) past participation in an MBSR group. In order to ensure stability 
of medication over the course of the study, if there had been a change in medication, 
patients were asked to wait 3 months before being enrolled in the next cohort for 
randomization and not to change regimens or dosages for the duration of the study. 
Results showed a greater improvement of symptoms (from moderate to severe) in patients 
from a group of MBSR in comparison to a control group. However, a rebound effect of 
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symptoms in follow-up was observed, that is, the rate of improvement due to the program 
was not found to be necessarily maintained over time. In addition, the control group also 
improved over time -perhaps due to the beneficial effects of attention, self-monitoring 
and the anticipation of participation in the MBSR group- and no differences were 
observed between groups in terms of quality of life, alterations of mood and spirituality. 
Finally, a recent study (81) comparing MBT with CBT has shown the former to be 
more effective in reducing IBS symptoms and to have a more lasting effect. 
3.3. ACT 
The application of ACT in IBS is still in an early stage, although significant steps 
have recently been made in that direction. For example, a pilot study (82) that analysed 
the effectiveness of ACT in adolescents with functional abdominal pain (some with IBS) 
shows that 12 to 14 sessions were effective in improving quality of life, levels of 
depression and anxiety and somatic complaints on the first month follow-up. 
Methodological shortcomings limit the conclusions, although this preliminary evidence 
suggests that ACT could be an effective approach to IBS. 
The first study (74) looking at the application of ACT to IBS specifically was 
conducted with the following exclusion criteria: 1) they were pregnant or breastfeeding, 
2) they reported any alarm symptoms suggestive of significant inflammatory or neoplastic 
gastrointestinal disorder (such as unexplained weight loss or unexplained rectal bleeding), 
and 3) they had a known cognitive impairment. A protocol that incorporated a one-day 
group workshop with a period of 2 months working with a self-help workbook (83) was 
used.  Despite the limitations of this study (highly selected population, very specific 
format of intervention and absence of a formal control group condition -this last limitation 
compensated by using a within subject design), results showed that ACT was effective at 
reducing symptoms, GSA and the use of IBS related avoidance behaviours, whilst 
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improving IBS related and general quality of life. These results held up at 6-month follow-
up with a trend for further gains (albeit not statistically significant).  
Part of this study also involved the development of a measure of psychological 
flexibility specific to IBS, the IBSAAQ (84). The development of this measure allowed 
the authors to explore the role of psychological flexibility in the biopsychosocial model 
of IBS. The results indicated that psychological flexibility was a significant predictor of 
all IBS related outcomes beyond the effects of symptom severity or cognitive variables. 
Beyond these findings, the development of this measure also allowed the authors to 
explore the putative mechanism through which an ACT intervention works, i.e. that 
improvement in outcomes occurs through an increase in psychological flexibility. The 
authors reported that all gains in IBS related outcomes following the ACT intervention 
were fully mediated by increases in psychological flexibility, lending therefore and extra 
layer of validity to the intervention model. 
4. FINAL CONSIDERATIONS 
The research conducted to date on the implementation of third-generation 
therapies to IBS shows promising results. In two recent reviews (85, 86) MBT when 
combined with CBT appears to be effective in reducing symptoms and improving quality 
of life in IBS. Further to that improvement in symptoms seems to occur even accounting 
for the different IBS presentation types (e.g. constipation or diarrhoea predominant). 
However, both reviews indicated that the results should be interpreted with caution 
because most of the studies were of poor quality and had many methodological limitations 
(small and heterogeneous samples, dropouts, risk of bias, etc.). 
On the other hand, ACT, by incorporating a more comprehensive model that is tied 
to a growth agenda (getting patients to enact their valued behaviours) rather than trying 
to address a deficit agenda (changing symptoms or thoughts), seems to be more effective.  
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Indeed, those patients who have trouble managing their bowel disorder and meet 
criteria for psychological comorbidity might be the most suitable ones for this kind of 
psychological therapy when these conditions get in the way of doing daily valued actions, 
and this results, progressively, in a restricted life. For example, the person’s reports of 
avoidance of different situations (e.g. personal relationships and intimate contact; work 
related situations; leisure or travelling) might be a good indicative of this. Nevertheless, 
a patient’s functional analysis of behaviour might be an effective general 
recommendation in order to explore if a pattern of PI is taking place. Extended in time, a 
pattern of PI might enable the person to act at the service of his or her valued directions, 
resulting in higher severity of symptoms (both physical and psychological) and less 
quality of life. ACT’s core therapeutic strategies could help alter a PI pattern and start 
building a more flexible and effective way of living with the illness. 
Although ACT could be conceived primarily as a form of individual therapy, it is 
extremely flexible and can be adapted to a group format, as well as be distance delivered, 
by telephone (87) or via Internet (75), which allows adjustment to the economic resources 
and time available in hospitals, centres of medical specialities and health centres. In 
addition, training in this therapeutic approach is not as long as in other intervention 
procedures (CBT, for example) and can be rolled out to different professionals (not just 
psychologists) (88).  
Empirical evidence of ACT for IBS, albeit preliminary, shows that the results are 
maintained in the long-term (up to six-months follow-up) and that improvements occur 
through the hypothesized path of increase in psychological flexibility. These results are 
very encouraging and invite different professionals to continue working on this 
direction.   
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These findings add to the extensive literature that has shown the usefulness of ACT 
in improving different medical conditions, by either promoting healthy behaviours 
(diabetes, smoking cessation, weight maintenance) or by changing the relation patients 
have with their difficult illness experiences (chronic pain), resulting in significant 
improvements in quality of life (74). 
Interesting pioneering work with patients with chronic pain (64) have shown the 
benefits of the joint work of different professionals -physiotherapists, occupational 
therapists, nurses, doctors and psychologists- in the patient’s experience of the illness and 
the related quality of life.  
Similarly, patients with other illnesses such as IBS (and other functional 
gastrointestinal disorders) may benefit from the interaction between gastroenterologists, 
nutritionists/dietitians, nurses and psychologists. Even though the purpose of 
pharmacological treatment is acting on the pathophysiological mechanism or, at least, on 
the symptoms, at the beginning it is not incompatible with psychological therapy, and 
IBS patients could benefit from the combination of both approaches. But the idea is that 
all professionals work together, in the same direction, to teach patients how to behave 
effectively in the presence of symptoms, feelings of shame or anxiety and, instead of 
trying to control them, learn to integrate them as part of their life. Thus, from a contextual 
perspective and with the empirical evidence supporting it, the goal will be to focus on 
training the person to observe and react to symptoms (stress, for example) in a way that 
is consistent to his/her objectives, goals and values. After all, IBS patients are people 
who, in addition to an illness, also have a life worth living, even if they have to carry that 
burden. 
To sum up, although ACT was originally designed for psychological disorders, it 
has recently been applied to medical conditions with very good results. The present 
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review is the first compilation of the new evidence from the psychological perspective 
for non- psychologists (in this case, for gastroenterologists). Despite the limitations of 
this first attempts (few studies with few and highly selected populations and other 
methodological shortcomings), this new direction is very promising, and more research 
is needed, so that we can address this syndrome in a more precise and efficient way. ACT 
is not difficult to apply (brief protocols can be used, and better results are obtained if 
different professionals work together, in the same direction) nor to evaluate (there are 
general measures of PI, as well as specific measures for IBS), so we hope this review 
sheds light on this option and more practitioners start learning and researching on how to 
help patients with IBS to better live their life, with IBS being just a part of it.  
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Table 1. Comparison between the main psychological therapies in terms of understanding of (psycho)pathology, objectives in therapy, 
techniques used, and strengths/weaknesses.                           
  
 UNDERSTANDING OF 
(PSYCHO)PATHOLOGY 
OBJECTIVES IN THERAPY HOW? (TECHNIQUES) STRENGTHS AND 
WEAKNESSES 
PSYCHODYNAMIC 
PSYCHOTHERAPY 
-  Mental phenomena arise from 
conflicting forces  symptoms as 
an attempt to restore balance 
-  Fixations / regressions in 
different stages of psycho-sexual 
development 
 
- Make conscious the unconscious 
(achieved by overcoming resistance 
to the memory of 
supressed/repressed events) 
- Free association, interpretation of 
dreams, hypnosis, etc. 
 
 
(-) Unverifiable assertions; theories 
not scientifically proven 
(-) Very long therapy  
 
 
COGNITIVE 
BEHAVIORAL 
THERAPY  
(CBT) 
- Psychological disorders are due to 
a distorted automatic processing of 
reality (disorders differ in the 
irrational cognitive content) 
 
- Relief of symptomatology 
(reduction / elimination of 
symptoms) 
- To change feelings or behavior, 
thoughts and beliefs must be 
changed 
- Cognitive techniques aimed at 
changing thoughts and beliefs (eg 
questioning of evidence, direct 
disputation, thought stopping, etc.) 
- Behavioral techniques (eg in vivo 
exposure, relaxation training, etc.) 
 (-) Lack of an unifying theoretical 
framework 
(+) Great expansion, much evidence 
(-) Unknown mechanism of action: 
effectiveness due to the behavioral 
component 
(-) Effects are not maintained in the 
long term 
CONTEXTUAL 
THERAPIES  
(ACT, mindfulness) 
-  Psychological disorders emerge 
from a pattern of psychological 
inflexibility (in presence of certain 
symptoms, the behaviour that 
follows them results 
counterproductive in the long term) 
the process underlying the different 
psychological disorders 
 
 
- Altering the pattern of 
psychological inflexibility by 
changing the function of symptoms  
(changing the way the person reacts 
to thoughts and feelings), rather 
than focusing on changing and 
eliminating symptoms 
- Training a behavioural repertoire 
of psychological flexibility towards 
the person’s valued-directions 
- Patient’s functional analysis of 
behaviour and creative hopelessness 
(analysis of thoughts and emotions, 
reactions to them and the short- and 
long-term effects derived from these 
reactions) 
- Values clarification 
- Mindfulness and defusion 
techniques (metaphors and 
experiential exercises) 
(+) Well defined theory (Relational 
Frame Theory) and philosophy 
(Functional Contextualism)( 
+) Therapy closely linked to 
research 
(+) Effects are maintained in the 
long term 
(+) Applicable to many different 
psychological disorders and 
medical conditions 
